🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Exciting time for Delta Genomics

We’re focused on improving cancer diagnoses to help patients and their families. Learn more nanosticsdx.com #WorldCancerDay #prostatecancer #MensHealth

Interesting reading for those flying on Air Canada or you can read the online version as well

Big day for Nanostics Inc. with the launch of our clinical study

We're going to CYTO 2019! Please DM John Lewis APCaRI, Desmond Pink @pinknewfie, Michael Wong, Diana Pham or Renjith Pillai Renjith Pillai to discuss clinical EV microflow assays, patient sample handling, early diagnostics or #ClarityDX Prostate. #CYTO2019 ISAC

Thank you Bird Dogs and donors! Funds endowed Frank & Carla Sojonky Chair; recruited John Lewis, who created APCaRI, researched metastasis targets and developed #ClarityDXProstate PCa test. Don’t miss; WLBG2019 and WWW.ccfgolf.ca #birddogs_PCa #diagnostics CureCancer

We're at ASEMV2019 in Pacific Grove, CA and looking forward to meeting you at our CEO John Lewis' talk and our booth to chat about EVs, uFCM and diagnostics! nanosticsdx.com/events #extracellularvesicles #ASEMV2019

We're expanding our Nanostics Inc. ClarityDX Prostate clinical validation study into the US with a recruitment site at Century Clinical Research Inc., Daytona Beach, FL. Read more at bit.ly/Nanostics nanosticsdx.com #clinicaltrials #ProstateCancer

Alberta Tech Entrepreneurs respond to AB budget omny.fm/shows/ryan-jes…

For more information about ClarityDX Prostate please go to nanosticsdx.com #GivingTuesday2019

Looking forward to an exciting week in the Valley!

Entos Pharmaceuticals Is Developing a DNA Vaccine Against COVID-19 Using Its Fusogenix Nanomedicine Platform business.financialpost.com/wcm/eb64d2bd-7… via National Post @Yeghealthcity UAlberta Research & Innovation @TECEdmonton Alberta Innovates #COVID19 #vaccine UAlberta Med & Dent

PR: “We’re joining the fight against COVID-19 by using our ClarityDX technology to rapidly and accurately predict which COVID-19 patients are at risk for developing severe disease,” John Lewis, Nanostics CEO @Yeghealthcity #COVID19 #covid19testing bit.ly/ClarityDXCovid…

Leadership should be a core value for all organizations trying to change the world #startupchats

Ceapro wins company of the year award at BIO Alberta #tecedmonton